Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2008-04-14

Clinical Trial Update: Effect of Iron Depletion by Phlebotomy Plus Lifestyle Changes vs. Lifestyle Changes Alone on Liver Damage in Patients With Nonalcoholic Fatty Liver Disease With Increased Iron Stores [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial examines whether iron depletion by phlebotomy plus lifestyle changes improves liver damage compared with lifestyle changes alone in pat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | Conditions: Nonalcoholic Fatty Liver Disease | Phase 3 | Status: UNKNOWN